GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Other Stockholders Equity

Renalytix (LSE:RENX) Other Stockholders Equity : £-1.23 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Renalytix Other Stockholders Equity?

Renalytix's Other Stockholders Equity for the quarter that ended in Mar. 2024 was £-1.23 Mil.

Renalytix's quarterly Other Stockholders Equity increased from Sep. 2023 (£-1.08 Mil) to Dec. 2023 (£10.00 Mil) but then declined from Dec. 2023 (£10.00 Mil) to Mar. 2024 (£-1.23 Mil).

Renalytix's annual Other Stockholders Equity declined from Jun. 2021 (£10.44 Mil) to Jun. 2022 (£-0.74 Mil) and declined from Jun. 2022 (£-0.74 Mil) to Jun. 2023 (£-1.15 Mil).


Renalytix Other Stockholders Equity Historical Data

The historical data trend for Renalytix's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Other Stockholders Equity Chart

Renalytix Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Stockholders Equity
Get a 7-Day Free Trial -0.65 0.73 10.44 -0.74 -1.15

Renalytix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.69 -1.15 -1.08 10.00 -1.23

Renalytix Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Renalytix Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Renalytix's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Renalytix (LSE:RENX) Business Description

Traded in Other Exchanges
Address
5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex 12-14-2012

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe 08-29-2013

Investing in Information

By Vanina Egea Vanina Egea 03-06-2014